Talcum Powder Litigation Report
Hot on the heels of separate $72 million and $55 million verdicts entered against Johnson & Johnson defendants, HarrisMartin has launched this Talcum Powder Litigation Report, an online-only resource dedicated solely to news on talc-based powder ovarian cancer claims.
SEARCH THE ARCHIVES
Issue #39, February 2020
FDA Holds Public Meeting on Testing Methods for Asbestos in Talc and Cosmetic Products Containing Talc
The U.S. Food and Drug Administration recently held a public meeting on testing methods for asbestos in talcum powder products during which it aimed to discuss and obtain scientific data and information on topics related to methodologies, terminologies, and criteria that could be used to measure the quantity of asbestos that may be present in talc and other consumer products.
The Plaintiffs’ Steering Committee has sent the court overseeing the talcum powder MDL docket a letter pointing to a recent developments from the International Agency for the Research on Cancer and the U.S. Food and Drug Administration related to investigating a possible link between talcum powder and ovarian cancer.
HarrisMartin: N.J. Jury Adds $750 Million Total in Punitive Damages to Earlier $37.3 Million Verdict in Asbestos Talc Trial
A New Jersey jury has added $750 million in punitive damages total to an earlier $37.3 million compensatory damage verdict at the conclusion of the second phase of a trial in which Johnson & Johnson’s Chief Executive Officer Alex Gorsky took the stand, HarrisMartin Publishing is reporting.
Calif. Court Rejects Plaintiff’s Motion for New Trial in Asbestos Talc Case that Ended in Defense Verdict
A California state court has denied a talcum powder plaintiffs’ motion for a new trial in wake of a defense verdict in favor of Johnson & Johnson, ruling that the FDA’s recent finding of asbestos in a single lot of Baby Powder was not sufficient to warrant a new trial.
A California resident has filed a Prop 65 lawsuit against a number of talc defendants, contending that the talcum powder industry has known that their products were contaminated with multiple carcinogens and reproductive toxins.
Issue #38, January 2020
Ky. Plaintiffs Ask Talcum Powder MDL Court to Remand Claims, Say Local Radiology Department is Proper Defendant
Kentucky residents with talcum powder claims pending in the national multidistrict litigation docket in New Jersey have asked the MDL Court to remand their lawsuit, challenging Johnson & Johnson’s position that an in-state defendant was fraudulently joined.
Defendants Point to Full Study Questioning Link Between Talc and Ovarian Cancer; Plaintiffs Say Defense Letter Lacks ‘Context’
Parties involved in the national multidistrict litigation docket for talcum powder personal injury claims have exchanged correspondence on the full release of a study examining a potential link between talcum powder usage and ovarian cancer, with the plaintiffs maintaining that the full study supports the opinions expressed by plaintiffs’ experts.
Defendants are urging the judge overseeing the federal talcum powder MDL docket to disregard four peer-reviewed publications published since the court oversaw a Daubert hearing in July, arguing that they do not bolster the reliability of plaintiffs’ experts’ opinions.
Issue #37, December 2019
A Missouri jury has reached a defense verdict in favor of Johnson & Johnson at the conclusion of a talcum powder ovarian cancer case, HarrisMartin Publishing is reporting.
The Mississippi Supreme Court has granted a motion by several Valeant companies to dismiss an appeal pending in a talcum powder action brought by the state’s Mississippi Attorney General, according to documents filed recently.